stockguard Tuesday, 10/20/20 07:13:25 AM Re: None Post # of 237 Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy https://www.globenewswire.com/news-release/2020/10/20/2110884/0/en/Affimed-and-NKMax-America-to-Study-the-Combination-of-AFM24-an-EGFR-Targeted-Innate-Cell-Engager-with-SNK01-Natural-Killer-Cell-Therapy.html